DNLI

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Denali Therapeutics Inc

NASDAQ | DNLI

19.41

USD

+$0.00

(

+0.00%

)

At Close (As of Nov 28, 2025)

$2.85B

Market Cap

-

P/E Ratio

-2.92

EPS

$26.18

52 Week High

$10.57

52 Week Low

HEALTHCARE

Sector

DNLI Chart

Recent Chart
Price Action

DNLI Technicals

Tags:

DNLI Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$7.8M
Total Revenue $0
Cost Of Revenue $7.8M
Costof Goods And Services Sold $7.8M
Operating Income -$487M
Selling General And Administrative $105M
Research And Development $396M
Operating Expenses $487M
Investment Income Net -
Net Interest Income $65M
Interest Income $65M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $9M
Income Before Tax -$423M
Income Tax Expense $68K
Interest And Debt Expense -
Net Income From Continuing Operations -$423M
Comprehensive Income Net Of Tax -
Ebit -$502M
Ebitda -$493M
Net Income -$423M

Revenue & Profitability

Earnings Performance

DNLI Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.4B
Total Current Assets $864M
Cash And Cash Equivalents At Carrying Value $175M
Cash And Short Term Investments $175M
Inventory -
Current Net Receivables $2.2M
Total Non Current Assets $510M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments $359M
Short Term Investments $657M
Other Current Assets $30M
Other Non Current Assets -
Total Liabilities $144M
Total Current Liabilities $102M
Current Accounts Payable $11M
Deferred Revenue -
Current Debt -
Short Term Debt $12M
Total Non Current Liabilities $42M
Capital Lease Obligations $49M
Long Term Debt -
Current Long Term Debt -
Long Term Debt Noncurrent -
Short Long Term Debt Total $49M
Other Current Liabilities $79M
Other Non Current Liabilities $5.6M
Total Shareholder Equity $1.2B
Treasury Stock -
Retained Earnings -$1.5B
Common Stock $1.8M
Common Stock Shares Outstanding $164M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow -$348M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $9M
Capital Expenditures $16M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$89M
Cashflow From Financing $484M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$423M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit -$7.8M
Total Revenue $0
Cost Of Revenue $7.8M
Costof Goods And Services Sold $7.8M
Operating Income -$487M
Selling General And Administrative $105M
Research And Development $396M
Operating Expenses $487M
Investment Income Net -
Net Interest Income $65M
Interest Income $65M
Interest Expense -
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $9M
Income Before Tax -$423M
Income Tax Expense $68K
Interest And Debt Expense -
Net Income From Continuing Operations -$423M
Comprehensive Income Net Of Tax -
Ebit -$502M
Ebitda -$493M
Net Income -$423M

DNLI News

DNLI Profile

Denali Therapeutics Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Denali Therapeutics Inc. is a leading biopharmaceutical company focused on developing innovative therapies for neurodegenerative diseases, addressing significant unmet medical needs in the healthcare sector. Headquartered in South San Francisco, California, Denali leverages its proprietary technology platforms to create disease-modifying treatments that target underlying biological mechanisms of neurological disorders. The company boasts a robust product pipeline, highlighting its expertise in transport biology and neuroinflammation, which positions it as a frontrunner in the neurotherapeutics field. Through its dedication to advancing clinical programs and cultivating strategic partnerships, Denali aims to improve patient outcomes in debilitating conditions such as Alzheimer's and Parkinson's diseases.

LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
KTTA
+61.79%
$1.71
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
AGNC
+1.53%
$10.56
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
SNAP
-0.39%
$7.61
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
ABEV
0.00%
$2.51
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
AFMD
-34.94%
$0.18
HBI
-0.45%
$6.59
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
MNDR
+39.47%
$2.65
SMCI
+1.07%
$32.83
BABA
+0.37%
$157.60
VSA
-14.30%
$0.12
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
SOUN
-1.00%
$11.82
HL
+6.60%
$15.97
HPE
+0.79%
$21.53
GRYP
-10.38%
$1.38
NGD
+6.66%
$7.84
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
RR
-3.35%
$3.46
CMND
-3.06%
$0.15
NVO
+3.50%
$48.71
MU
+2.55%
$230.26
ET
+0.98%
$16.43
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
TMC
+7.36%
$5.83
CRCL
+3.60%
$72.64
PTCT
+4.00%
$86.25
BQ
+29.54%
$2.28
PBR
+0.31%
$12.66
VZ
+0.71%
$40.88
QUBT
-1.20%
$11.46
LPTX
+368.57%
$2.05
NVDA
+1.37%
$180.26
VHAI
0.00%
$0.00
BYND
+19.00%
$1.02
INHD
-16.32%
$0.22
ZYXI
+115.62%
$1.59
VINE
+10.76%
$0.39
AMZE
+10.76%
$0.39
ONDS
-2.36%
$8.24
AMBR
+56.32%
$2.47
BITF
+11.91%
$3.10
PLUG
+1.53%
$1.98
NIO
-0.72%
$5.46
KTTA
+61.79%
$1.71
IPG
-1.95%
$24.57
ASST
+1.80%
$1.13
CLSK
+13.79%
$13.45
AXDX
-61.36%
$0.03
INTC
+2.73%
$36.81
BMNR
+9.78%
$31.74
GPUS
+15.78%
$0.33
GOOGL
-1.07%
$319.95
SPRC
-9.01%
$2.22
ADAP
-15.14%
$0.05
YGMZ
-34.15%
$0.12
MARA
-0.53%
$11.11
WULF
+6.45%
$14.84
HOOD
+10.92%
$128.20
RUBI
-8.19%
$0.21
F
+0.15%
$13.19
SNDK
-2.47%
$215.04
SOND
-23.45%
$0.12
RMBL
+60.50%
$3.21
TLRY
+4.76%
$1.03
BTBT
+2.65%
$2.32
LNW
-3.71%
$86.22
CHR
-4.86%
$0.04
ADD
-25.47%
$0.05
GRAB
+1.52%
$5.32
RIG
+6.17%
$4.30
SRM
+53.27%
$10.30
PLTR
+1.35%
$165.77
PFE
-0.03%
$25.71
AAPL
+0.20%
$277.55
HBAN
+0.55%
$16.27
AGNC
+1.53%
$10.56
BTG
+3.23%
$4.47
BAC
+0.97%
$52.99
CCL
-1.12%
$25.43
SNAP
-0.39%
$7.61
TWOH
0.00%
$0.00
ACHR
+1.49%
$7.49
RGTI
-1.95%
$25.57
CRWV
+4.20%
$74.29
WLGS
-5.57%
$0.04
ABEV
0.00%
$2.51
MTSR
-0.35%
$70.50
T
-0.15%
$25.82
AEHL
+8.43%
$3.47
IREN
+2.06%
$48.45
NTNX
-17.74%
$48.34
MSFT
+1.78%
$485.50
ITUB
+3.23%
$7.66
NOK
+0.33%
$6.08
DEFT
+20.86%
$1.39
AFMD
-34.94%
$0.18
HBI
-0.45%
$6.59
HPQ
-1.39%
$23.98
BURU
+7.72%
$0.22
PLTZ
-2.62%
$7.43
APLD
+5.05%
$24.94
MNDR
+39.47%
$2.65
SMCI
+1.07%
$32.83
BABA
+0.37%
$157.60
VSA
-14.30%
$0.12
NVTS
+3.86%
$8.34
OSCR
+8.54%
$18.16
SOUN
-1.00%
$11.82
HL
+6.60%
$15.97
HPE
+0.79%
$21.53
GRYP
-10.38%
$1.38
NGD
+6.66%
$7.84
MODV
-25.22%
$0.43
AMCR
+1.29%
$8.62
KSS
+7.49%
$24.10
BTE
-0.31%
$3.16
RR
-3.35%
$3.46
CMND
-3.06%
$0.15
NVO
+3.50%
$48.71
MU
+2.55%
$230.26
ET
+0.98%
$16.43
NAKA
+7.20%
$0.49
KDLY
+7.20%
$0.49
TMC
+7.36%
$5.83
CRCL
+3.60%
$72.64
PTCT
+4.00%
$86.25
BQ
+29.54%
$2.28
PBR
+0.31%
$12.66
VZ
+0.71%
$40.88
QUBT
-1.20%
$11.46
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.